REDUCED BETA-AMYLOID RESPONSE IN LYMPHOCYTES OF PATIENTS WITH ALZHEIMERS-DISEASE

Citation
B. Bondy et al., REDUCED BETA-AMYLOID RESPONSE IN LYMPHOCYTES OF PATIENTS WITH ALZHEIMERS-DISEASE, Pharmacopsychiatry, 28(4), 1995, pp. 143-146
Citations number
18
Categorie Soggetti
Psychiatry,"Pharmacology & Pharmacy
Journal title
ISSN journal
01763679
Volume
28
Issue
4
Year of publication
1995
Pages
143 - 146
Database
ISI
SICI code
0176-3679(1995)28:4<143:RBRILO>2.0.ZU;2-5
Abstract
The beta-amyloid peptide (beta A4) is a principal constituent of senil e plagues and is thought to play a major role in the pathophysiology o f Alzheimer's disease (AD). Although the mechanism of beta-A4 neurotox icity is still a matter of debate, one of its effects might be a desta bilization of cellular calcium homeostasis, thus promoting neuronal da mage. The influence of the toxic fragment beta A25-35 on the mitogen-i nduced rise in the intracellular calcium concentration ([Ca2+](i)) in lymphocytes of AD (n=13) and depressive patients (n=14) as well as in healthy controls was therefore investigated (n=16), The results showed a significant increase in the mitogen-induced calcium signal with lym phocytes of healthy controls and depressive patients. This beta A25-35 -induced amplification was significantly lower in AD patients as compa red to healthy controls but not as compared to depressive patients. Th e results thus confirm a postulated decreased beta-amyloid sensitivity in AD lymphocytes. However, this effect might not be as pronounced or as specific as recently decribed by Eckert et al., (1993b).